Gesund. Innovativ. - im BioCon Valley Mecklenburg-Vorpommern ...

a n n ual report 20 07 he a lt h eco n omy a nd life s c ience in m ec klenburg -vo rpommern
s s s s s
6
Welcome
Dear reader,
The annual report which lies before you from BioCon Valley ® – the initiative for Life Science and
Health Economy of the German federal state Mecklenburg-Vorpommern – presents you with a further
eventful year of diverse activities and numerous successes for Mecklenburg-Vorpommern. The
indent for the BioCon Valley ® GmbH to coordinate the health economy has been secured for the
next years is a matter of great pride and a reason to be thankful.
With this development the BioCon Valley ® initiative can contribute even more strongly and specifically
to the advantageous development of the sector in this federal state and the establishment
of the location Mecklenburg-Vorpommern on a national and international level. In 2007 BioCon
Valley ® was especially able to utilise the activities surrounding the G8 summit in Heiligendamm,
the German Reunification Day on 3rd October in Schwerin and the leading trade fairs Arab Health
in Dubai und BIOTECHNIKA in Hanover, as a showcase for the sector. Naturally these results owed
much to the efforts of many large and small contributors from the economic and scientific communities
of the state, such as the numerous national pilot schemes in the areas of health economy,
agro-biotechnology and – featuring as a new field of activity – industrial biotechnology. The vital
presence of international projects with the Baltic Sea states in the ScanBalt network and with East
Asia could also be further intensified.
The successful participation as a cooperation partner in the north German network “biokatalyse2021”,
the winning region in the nationwide cluster competition for industrial biotechnology,
plays no small part in showing the potential offered by a close liaison among the players in north
Germany. Seen in this perspective, the successful conclusion of an agreement for long-term cooperation
with the mutual life science initiatives of Hamburg and Schleswig-Holstein, the NORGENTA
GmbH, is especially pleasing. The formal cooperation agreement under the direction of the North
German prime-ministers and First Mayor of the Free and Hanseatic City of Hamburg was concluded
on 30th October.
The health economy was also able to confirm its position more and more in the eyes of the end
user as a stable, common umbrella, encompassing the entire value creation chain consisting
of research, development, production, and service. However, a great deal of groundwork is still
necessary for the formation of a network for the most diverse of protagonists – and the required
creation of an awareness comprehending the mutually sustaining sectors and the resulting large
market. To this end, the national conference for the health economy sector in Rostock has become
established since 200 and was again held in 2007. The decision to dedicate the 3rd “National
Conference for the Health Economy” to the subject of the “Complementary and Alternative Medicine
as an Economic Factor: Chances, Limits, Standards” was wholly conscious. Despite the dissociation
from orthodox medicine, this is an important market, in which approximately 20% of the
around 0 billion Euros annual health economy volume in Germany is achieved.